Antiva Biosciences, Inc.
Amendment
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Oct 11, 2024
Total Offering
$52,999,990
Amount Sold
$38,535,985
Investors
21
First Sale
Apr 24, 2023
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Kristine Ball | Related Person |
| Gail Maderis | Related Person |
| Wende Hutton | Related Person |
| Clifford Samuel | Related Person |
| Beni Rovinski | Related Person |
| Brian Goodman | Related Person |
| Florencia Segal | Related Person |
| Elaine Chien | Related Person |
| Raju Gadiraju | Related Person |
| Sarah Walter | Related Person |
Company
SEC Filing
0001563355-24-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free